APA (7th ed.) Citation

Trivedi, N. D., Armstrong, S., Wang, H., Hartley, M., Deeken, J., Ruth He, A., . . . Pishvaian, M. J. (2021). A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies. Cancer Medicine, 10(6), 1944. https://doi.org/10.1002/cam4.3672

Chicago Style (17th ed.) Citation

Trivedi, Neel D., et al. "A Phase I Trial of the MTOR Inhibitor Temsirolimus in Combination with Capecitabine in Patients with Advanced Malignancies." Cancer Medicine 10, no. 6 (2021): 1944. https://doi.org/10.1002/cam4.3672.

MLA (9th ed.) Citation

Trivedi, Neel D., et al. "A Phase I Trial of the MTOR Inhibitor Temsirolimus in Combination with Capecitabine in Patients with Advanced Malignancies." Cancer Medicine, vol. 10, no. 6, 2021, p. 1944, https://doi.org/10.1002/cam4.3672.